Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Analysis of Initial Surgical Intervention versus Neoadjuvant Treatment in Pancreatic Cancer with Venous Involvement: A Multicenter Retrospective Study

  • By

  • Asif Halimi

  • Eline S. Zwart

  • Bengi S. Yilmaz

  • Benediktas Kurlinkus

  • Reea Ahola

  • Marco Del Chiaro

  • Ernesto Sparrelid

  • Elena Rangelova

  • Laura Maggino

  • Giuseppe Malleo

  • Gabriella Lionetto

  • Roberto Salvia

  • Keith J. Roberts

  • Francesco Giovinazzo

  • Massimo Falconi

  • Stefano Crippa

  • Giulio Belfiori

  • Geert Kazemier

  • Patrick Maisonneuve

  • Johanna Laukkarinen

  • Güralp O. Ceyhan

  • September 22, 2026

Share

Original Source(s)

Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis

  • by Asif Halimi, Eline S. Zwart, Bengi S. Yilmaz, Benediktas Kurlinkus, Reea Ahola, Marco Del Chiaro, Ernesto Sparrelid, Elena Rangelova, Laura Maggino, Giuseppe Malleo, Gabriella Lionetto, Roberto Salvia, Keith J. Roberts, Francesco Giovinazzo, Massimo Falconi, Stefano Crippa, Giulio Belfiori, Geert Kazemier, Patrick Maisonneuve, Johanna Laukkarinen, Güralp O. Ceyhan

  • September 22, 2026

Related Content

Diagnostic interpretation of CFH expression in pan-cancer analyses: the importance of factor H–like 1 isoform resolution

FDA Investigates Malignancy Risk Linked to Zolgensma Gene Therapy

Vector DNA integration was identified near or within the GLI1 oncogene in tumors from two treated patients

  • November 11, 2026

  • 3 min
Decoding cancer-associated ribosomal protein mutations: A new frontier in cancer and ribosome biology